Both these cell types have been reported to undergo cytokine reprogramming during conditions of heightened chronic inflammation and a shifting cytokine milieu that develop during a number of CD4 T cell-mediated autoimmune diseases (6, 7, 13, 19, 50, 51). The gene discussed is CD4; the disease is autoimmune disease.